These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
244 related articles for article (PubMed ID: 10699878)
41. Preservation of contractile characteristics of human myocardium in multi-day cell culture. Janssen PM; Lehnart SE; Prestle J; Hasenfuss G J Mol Cell Cardiol; 1999 Aug; 31(8):1419-27. PubMed ID: 10423340 [TBL] [Abstract][Full Text] [Related]
42. Characterisation of the function of adult guinea-pig ventricular myocytes following co-culture with neonatal rat myocytes. Kent NS; Davia K; Harding SE Basic Res Cardiol; 1999 Feb; 94(1):9-14. PubMed ID: 10097825 [TBL] [Abstract][Full Text] [Related]
43. Blinded Contractility Analysis in hiPSC-Cardiomyocytes in Engineered Heart Tissue Format: Comparison With Human Atrial Trabeculae. Mannhardt I; Eder A; Dumotier B; Prondzynski M; Krämer E; Traebert M; Söhren KD; Flenner F; Stathopoulou K; Lemoine MD; Carrier L; Christ T; Eschenhagen T; Hansen A Toxicol Sci; 2017 Jul; 158(1):164-175. PubMed ID: 28453742 [TBL] [Abstract][Full Text] [Related]
44. 24-h Langendorff-perfused neonatal rat heart used to study the impact of adenoviral gene transfer. Wiechert S; El-Armouche A; Rau T; Zimmermann WH; Eschenhagen T Am J Physiol Heart Circ Physiol; 2003 Aug; 285(2):H907-14. PubMed ID: 12663262 [TBL] [Abstract][Full Text] [Related]
45. Spontaneous Formation of Extensive Vessel-Like Structures in Murine Engineered Heart Tissue. Stoehr A; Hirt MN; Hansen A; Seiffert M; Conradi L; Uebeler J; Limbourg FP; Eschenhagen T Tissue Eng Part A; 2016 Feb; 22(3-4):326-35. PubMed ID: 26763667 [TBL] [Abstract][Full Text] [Related]
46. Real-Time Force and Frequency Analysis of Engineered Human Heart Tissue Derived from Induced Pluripotent Stem Cells Using Magnetic Sensing. Bielawski KS; Leonard A; Bhandari S; Murry CE; Sniadecki NJ Tissue Eng Part C Methods; 2016 Oct; 22(10):932-940. PubMed ID: 27600722 [TBL] [Abstract][Full Text] [Related]
47. Computational analysis of contractility in engineered heart tissue. Mathews G; Sondergaard C; Jeffreys A; Childs W; Le BL; Sahota A; Najibi S; Nolta J; Si MS IEEE Trans Biomed Eng; 2012 May; 59(5):1429-35. PubMed ID: 22361653 [TBL] [Abstract][Full Text] [Related]
48. Effect of isoproterenol on local contractile behaviors of rat cardiomyocytes measured by atomic force microscopy. Mizutani Y; Kawahara K; Okajima T Curr Pharm Biotechnol; 2012 Nov; 13(14):2599-603. PubMed ID: 22039809 [TBL] [Abstract][Full Text] [Related]
49. High-efficiency, long-term cardiac expression of foreign genes in living mouse embryos and neonates. Christensen G; Minamisawa S; Gruber PJ; Wang Y; Chien KR Circulation; 2000 Jan; 101(2):178-84. PubMed ID: 10637206 [TBL] [Abstract][Full Text] [Related]
50. Contractile and electrophysiologic characterization of optimized self-organizing engineered heart tissue. Sondergaard CS; Mathews G; Wang L; Jeffreys A; Sahota A; Wood M; Ripplinger CM; Si MS Ann Thorac Surg; 2012 Oct; 94(4):1241-8; discussion 1249. PubMed ID: 22795054 [TBL] [Abstract][Full Text] [Related]
51. Dynamic Control of Contractile Force in Engineered Heart Tissue. Li H; Sundaram S; Hu R; Lou L; Sanchez F; McDonald W; Agarwal A; Chen CS; Bifano TG IEEE Trans Biomed Eng; 2023 Jul; 70(7):2237-2245. PubMed ID: 37021994 [TBL] [Abstract][Full Text] [Related]
52. Piezo-bending actuators for isometric or auxotonic contraction analysis of engineered heart tissue. Mannhardt I; Warncke C; Trieu HK; Müller J; Eschenhagen T J Tissue Eng Regen Med; 2019 Jan; 13(1):3-11. PubMed ID: 30334614 [TBL] [Abstract][Full Text] [Related]
53. Reproducibility of drug-induced effects on the contractility of an engineered heart tissue derived from human pluripotent stem cells. Arefin A; Mendoza M; Dame K; Garcia MI; Strauss DG; Ribeiro AJS Front Pharmacol; 2023; 14():1212092. PubMed ID: 37469866 [No Abstract] [Full Text] [Related]
55. 3D engineered heart tissue for replacement therapy. Eschenhagen T; Didié M; Münzel F; Schubert P; Schneiderbanger K; Zimmermann WH Basic Res Cardiol; 2002; 97 Suppl 1():I146-52. PubMed ID: 12479248 [TBL] [Abstract][Full Text] [Related]
56. Variable optimization for the formation of three-dimensional self-organized heart muscle. Khait L; Hodonsky CJ; Birla RK In Vitro Cell Dev Biol Anim; 2009 Dec; 45(10):592-601. PubMed ID: 19756885 [TBL] [Abstract][Full Text] [Related]
57. Automated Contraction Analysis of Human Engineered Heart Tissue for Cardiac Drug Safety Screening. Mannhardt I; Saleem U; Benzin A; Schulze T; Klampe B; Eschenhagen T; Hansen A J Vis Exp; 2017 Apr; (122):. PubMed ID: 28448053 [TBL] [Abstract][Full Text] [Related]
58. Distribution and characteristics of telocytes as nurse cells in the architectural organization of engineered heart tissues. Zhou J; Wang Y; Zhu P; Sun H; Mou Y; Duan C; Yao A; Lv S; Wang C Sci China Life Sci; 2014 Feb; 57(2):241-7. PubMed ID: 24430556 [TBL] [Abstract][Full Text] [Related]
59. A novel method to study contraction characteristics of a single cardiac myocyte using carbon fibers. Yasuda SI; Sugiura S; Kobayakawa N; Fujita H; Yamashita H; Katoh K; Saeki Y; Kaneko H; Suda Y; Nagai R; Sugi H Am J Physiol Heart Circ Physiol; 2001 Sep; 281(3):H1442-6. PubMed ID: 11514317 [TBL] [Abstract][Full Text] [Related]
60. Organ-specific model of simulated ischemia/reperfusion and hyperglycemia based on engineered heart tissue. Pálóczi J; Paál Á; Pigler J; Kiss B; Rhoden A; Varga ZV; Ferdinandy P; Eschenhagen T; Görbe A Vascul Pharmacol; 2023 Oct; 152():107208. PubMed ID: 37572973 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]